BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 15340760)

  • 1. Quality-adjusted survival analysis shows differences in outcome after immunosuppression or bone marrow transplantation in aplastic anemia.
    Viollier R; Passweg J; Gregor M; Favre G; Kühne T; Nissen C; Gratwohl A; Tichelli A
    Ann Hematol; 2005 Jan; 84(1):47-55. PubMed ID: 15340760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of long-term outcome of children with severe aplastic anemia treated with immunosuppression versus bone marrow transplantation.
    Gillio AP; Boulad F; Small TN; Kernan NA; Reyes B; Childs BH; Brochstein JA; Laver J; Castro-Malaspina H; O'Reilly RJ
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):18-24. PubMed ID: 9209737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CsA-based post-graft immunosuppression: the main factor for improving outcome of allografted patients with acquired aplastic anemia. A retrospective survey by the Spanish Group of Hematopoietic Transplantation.
    Arranz R; Conde E; Rodriguez-Salvanés F; Pajuelo FJ; Cabrera R; Sanz MA; Petit J; Bueno J; Maldonado J; Odriozola J; Conde JG; Brunet S; Carreras E; Iriondo A; Fernández-Rañada JM; Marín P;
    Bone Marrow Transplant; 2002 Feb; 29(3):205-11. PubMed ID: 11859392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Favorable current prognosis after HLA-identical bone marrow transplantation for children with required severe aplastic anemia; evaluation of 30 years of bone marrow transplantation at the Leiden University Medical Center].
    van Steekelenburg M; van Weel-Sipman MH; Zwinderman AH; Hoogerbrugge PM; Vossen JM; Egeler RM
    Ned Tijdschr Geneeskd; 2002 Aug; 146(33):1542-6. PubMed ID: 12212502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aplastic anemia--clinical characteristics and survival analysis].
    Milosević R; Antonijević N; Janković G; Babić D; Colović M
    Srp Arh Celok Lek; 1998; 126(7-8):234-8. PubMed ID: 9863388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation.
    Safadi R; Or R; Ilan Y; Naparstek E; Nagler A; Klein A; Ketzinel-Gilaad M; Ergunay K; Danon D; Shouval D; Galun E
    Bone Marrow Transplant; 2001 Jan; 27(2):183-90. PubMed ID: 11281388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second bone marrow transplantation for severe aplastic anemia: analysis of 34 cases.
    de Medeiros CR; Bitencourt MA; Medeiros BC; Ioshizumi L; Pasquini R
    Bone Marrow Transplant; 2001 Nov; 28(10):941-4. PubMed ID: 11753548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unrelated bone marrow transplantation for beta-thalassemia patients: The experience of the Italian Bone Marrow Transplant Group.
    La Nasa G; Argiolu F; Giardini C; Pession A; Fagioli F; Caocci G; Vacca A; De Stefano P; Piras E; Ledda A; Piroddi A; Littera R; Nesci S; Locatelli F
    Ann N Y Acad Sci; 2005; 1054():186-95. PubMed ID: 16339665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with marrow transplantation or immunosuppression of childhood acquired severe aplastic anemia: a report from the EBMT SAA Working Party.
    Locasciulli A; van't Veer L; Bacigalupo A; Hows J; Van Lint MT; Gluckman E; Nissen C; McCann S; Vossen J; Schrezenmeier A
    Bone Marrow Transplant; 1990 Sep; 6(3):211-7. PubMed ID: 2252962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran.
    Zakerinia M; Khojasteh HN; Ramzi M; Haghshenas M
    Transplant Proc; 2005 Dec; 37(10):4477-81. PubMed ID: 16387149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved survival in severe acquired aplastic anemia of childhood.
    Fouladi M; Herman R; Rolland-Grinton M; Jones-Wallace D; Blanchette V; Calderwood S; Doyle J; Halperin D; Leaker M; Saunders EF; Zipursky A; Freedman MH
    Bone Marrow Transplant; 2000 Dec; 26(11):1149-56. PubMed ID: 11149724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABO blood group barrier in allogeneic bone marrow transplantation revisited.
    Seebach JD; Stussi G; Passweg JR; Loberiza FR; Gajewski JL; Keating A; Goerner M; Rowlings PA; Tiberghien P; Elfenbein GJ; Gale RP; van Rood JJ; Reddy V; Gluckman E; Bolwell BJ; Klumpp TR; Horowitz MM; Ringdén O; Barrett AJ;
    Biol Blood Marrow Transplant; 2005 Dec; 11(12):1006-13. PubMed ID: 16338623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
    Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
    Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow transplantation in adults with thalassemia: Treatment and long-term follow-up.
    Gaziev J; Sodani P; Polchi P; Andreani M; Lucarelli G
    Ann N Y Acad Sci; 2005; 1054():196-205. PubMed ID: 16339666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent improvement in outcome of unrelated donor transplantation for aplastic anemia.
    Viollier R; Socié G; Tichelli A; Bacigalupo A; Korthof ET; Marsh J; Cornish J; Ljungman P; Oneto R; Békássy AN; Fuehrer M; Maury S; Schrezenmeier H; van Lint MT; Wojcik D; Locasciulli A; Passweg JR
    Bone Marrow Transplant; 2008 Jan; 41(1):45-50. PubMed ID: 17982502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome following autologous and allogeneic blood and marrow transplantation for relapsed diffuse large-cell non-Hodgkin's lymphoma.
    Aksentijevich I; Jones RJ; Ambinder RF; Garrett-Mayer E; Flinn IW
    Biol Blood Marrow Transplant; 2006 Sep; 12(9):965-72. PubMed ID: 16920563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation.
    Spinelli S; Chiodi S; Costantini S; Van Lint MT; Raiola AM; Ravera GB; Bacigalupo A
    Haematologica; 2003 Oct; 88(10):1163-8. PubMed ID: 14555313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aetiology of severe aplastic anaemia and outcome after allogeneic bone marrow transplantation or immunosuppression therapy. Working Party on Severe Aplastic Anaemia of the European Blood and Marrow Transplantation Group.
    Bacigalupo A
    Eur J Haematol Suppl; 1996; 60():16-9. PubMed ID: 8987236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Twenty years of severe aplastic anemia treatment at Department of Hematology, University Department of Medicine, Zagreb University Hospital Center, Zagreb, Croatia].
    Mrsić M; Seiwerth RS; Labar B; Bogdanić V; Nemet D; Duraković N; Mikulić M; Sertić D; Aurer I; Radman I; Zupancić-Salek S
    Acta Med Croatica; 2009 Jun; 63(3):209-14. PubMed ID: 19827347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of severe aplastic anemia].
    Gratwohl A; Osterwalder B; Nissen C; Leibundgut U; Signer E; Lüthy A; Jeannet M; Speck B
    Schweiz Med Wochenschr; 1981 Oct; 111(41):1520-2. PubMed ID: 7031870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.